molecular imaging

CellSight Technologies is a company founded by Dr. Sanjiv 'Sam' Gambhir and co-founded by Mr. Quezada and Dr. Shahriar Yaghoubi to commercialize molecular imaging technologies developed in Dr. Gambhir's lab at Stanford University. Guided by CEO Aruna Bodapati Gambhir, the company pursues precision health and improved patient outcomes through molecular imaging and targeted imaging agents.

development of targeted imaging agentsoptical imagingPET imagingphotoacoustic imaging

Compsit3 is an early-stage molecular imaging company focused on the development and commercialization of molecular imaging probes for the non-invasive detection of tissue inflammation. Its lead technology is CS-31, an imaging probe that targets and illuminates C3d deposited in tissues, a marker of immune activation, intended as a safer alternative to tissue biopsy for assessing disease activity and therapeutic response to complement inhibitors and other immune modulators.

companion diagnosticsdevelopment and commercialization of imaging probes

Cyclomedica is a global nuclear medicine and molecular imaging provider based in Australia, operating under Cyclopharm Limited (ASX:CYC). Its flagship product, Technegas®, is a diagnostic lung imaging technology for visualisation of pulmonary ventilation and lung function, distributed in 65 countries. Technegas gained approval for distribution in the USA, with US market debut in Q4 2023 following USFDA approval.

functional lung imagingmedical equipment developmentnuclear medicinePET imagingradiopharmaceutical developmentSPECT imaging